Literature DB >> 22341752

Algorithm proposal based on the C. Diff Quik Chek Complete ICT device for detecting Clostridium difficile infection.

M A Angeles Orellana-Miguel1, Adela Alcolea-Medina, Laura Barrado-Blanco, Joaquín Rodriguez-Otero, Fernando Chaves-Sánchez.   

Abstract

OBJECTIVE: To assess a new immunochromatography (ICT) test that detects glutamate dehydrogenase (GDH) antigen and Clostridium difficile toxin A/B simultaneously, and to propose an algorithm for the diagnosis of C. difficile infection (CDI) based on this test.
METHODS: We analysed 970 stool samples. Discrepant results between GDH and toxin A/B were resolved using toxigenic culture as the reference.
RESULTS: This test enabled us to obtain a conclusive result in <30min in 93.8% of the samples. Among the discrepant results (GDH (+)/Toxin A/B (-)), 41.7% (25/60) were found to be toxigenic C. difficile by toxigenic culture.
CONCLUSION: This test has a high sensitivity and specificity for the diagnosis of CDI.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22341752     DOI: 10.1016/j.eimc.2012.01.003

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  7 in total

Review 1.  The Point-of-Care Laboratory in Clinical Microbiology.

Authors:  Michel Drancourt; Audrey Michel-Lepage; Sylvie Boyer; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

2.  Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screening.

Authors:  K A Morris; L R Macfarlane-Smith; M H Wilcox
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-16       Impact factor: 3.267

3.  Risk factors associated with Clostridium difficile infection in adult oncology patients.

Authors:  Analia Rodríguez Garzotto; Antonio Mérida García; Nerea Muñoz Unceta; M Mar Galera Lopez; M Ángeles Orellana-Miguel; C Vanesa Díaz-García; Susana Cortijo-Cascajares; Hernán Cortes-Funes; M Teresa Agulló-Ortuño
Journal:  Support Care Cancer       Date:  2014-11-20       Impact factor: 3.603

4.  Potential role of post-transplant hypogammaglobulinemia in the risk of Clostridium difficile infection after kidney transplantation: a case-control study.

Authors:  Julia Origüen; Mario Fernández-Ruiz; Carlos Lumbreras; María Ángeles Orellana; Francisco López-Medrano; Tamara Ruiz-Merlo; Rafael San Juan; Ana García-Reyne; Esther González; Natalia Polanco; Estela Paz-Artal; Amado Andrés; José María Aguado
Journal:  Infection       Date:  2015-02-13       Impact factor: 3.553

5.  Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.

Authors:  Lee F Schroeder; Elizabeth Robilotti; Lance R Peterson; Niaz Banaei; David W Dowdy
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

6.  Rapid diagnosis of gastrointestinal tract infections due to parasites, viruses, and bacteria.

Authors:  Luz Balsalobre-Arenas; Teresa Alarcón-Cavero
Journal:  Enferm Infecc Microbiol Clin       Date:  2017-02-24       Impact factor: 1.731

7.  Significance of a polymerase chain reaction method in the detection of Clostridioides difficile.

Authors:  J Jaqueti Aroca; L M Molina Esteban; I García-Arata; J García-Martínez; I Cano De Torres; S Prieto Menchero
Journal:  Rev Esp Quimioter       Date:  2021-02-19       Impact factor: 1.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.